NCT07495644

Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 95 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To study the efficacy of different biological treatment on patient with inflammatory bowel disease after one year of treatment in upper egypt

Detailed description

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic inflammatory disorder that requires long-term management. Biological therapies have significantly improved outcomes in patients with moderate to severe disease; however, variability in treatment response remains a challenge. This study aims to evaluate and compare the efficacy of different biological treatments in patients with IBD in Upper Egypt after one year of therapy. Clinical outcomes, including disease activity and remission rates, will be assessed to determine treatment effectiveness.

Conditions

• Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)

Interventions

Type	Name	Description
BIOLOGICAL	adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab	Efficacy of different biological treatment on patient with inflammatory bowel disease

Timeline

• Start date: 2026-03-01
• Primary completion: 2027-03-01
• Completion: 2027-06-01
• First posted: 2026-03-27
• Last updated: 2026-03-27

Regulatory

• FDA-regulated drug study